Skip to main content

Graves Disease

Juan Perez, D.O. Reviewed 04/2024
 


BASICS

DESCRIPTION

Autoimmune disease in which thyroid-stimulating hormone receptor (TSHR) activation by thyrotropin receptor antibodies (TRAb) cause increased thyroid hormone secretion. Most common ca...

DIAGNOSIS

HISTORY

  • Tachycardia, palpitations

  • Tremor, restlessness

  • Hyperactivity, anxiety, emotional lability, insomnia, poor concentration

  • Sweating, heat intolerance

  • Pruritus, skin changes

  • Weight loss with i...

TREATMENT

GENERAL MEASURES

The goal is to correct the hypermetabolic state with the fewest side effects and lowest incidence of posttreatment hypothyroidism. 

MEDICATION

First Line

  • Antithyroid drugs: meth...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

Check TSH and T4 levels every 1 to 2 months for the first 6 months after treatment, then every 3 months for a year, and then every 6 to 12 month...

REFERENCES

1
Ren  Z, Qin  L, Wang  JQ, et al. Comparative efficacy of four treatments in patients with Graves’ disease: a network meta-analysis. Exp Clin Endocrinol Diabetes. &#...

ADDITIONAL READING

Lane L, Wood C, Cheetham T. Graves' disease: moving forwards. Arch Dis Child. 2023;108(4):276–281.  

SEE ALSO

Algorithms: Anxiety; Cardiac Arrhythmias; Weight Loss, Unintentional 

CODES

ICD10

  • E05.00 Thyrotoxicosis w diffuse goiter w/o thyrotoxic crisis

  • E05.01 Thyrotoxicosis w diffuse goiter w thyrotoxic crisis or storm

  • E05.20 Thyrotoxicosis w toxic multinod goiter w/o thyrotoxic c...

CLINICAL PEARLS

  • Graves disease accounts for 60–80% of all cases of hyperthyroidism.

  • Potential morbidities of hyperthyroidism include ophthalmopathy, atrial fibrillation, congestive heart failure (CHF),...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×